RT Journal Article
SR Electronic
T1 Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.04.27.22274348
DO 10.1101/2022.04.27.22274348
A1 Lucas, Sionne EM
A1 Raspin, Kelsie
A1 Mackintosh, John
A1 Glaspole, Ian
A1 Reynolds, Paul N
A1 Chia, Collin
A1 Grainge, Christopher
A1 Kendall, Peter
A1 Troy, Lauren
A1 Schwartz, David A
A1 Wood-Baker, Richard
A1 Walsh, Simon LF
A1 Moodley, Yuben
A1 Robertson, James
A1 Macansh, Sacha
A1 Walters, Eugene H
A1 Chambers, Daniel
A1 Corte, Tamera J
A1 Dickinson, Joanne L
YR 2022
UL http://medrxiv.org/content/early/2022/07/06/2022.04.27.22274348.abstract
AB Family history is amongst the strongest risk factors for interstitial lung disease (ILD), with emerging evidence for a shared genetic aetiology across ILD subtypes. Recruited families comprised at least two first-degree relatives who had been previously diagnosed with an ILD. All living cases and available unaffected first-degree relatives underwent a clinical examination for evidence of ILD. Preclinical ILD was diagnosed in 47.7% of first-degree relatives who had previously self-reported as unaffected. This study highlights the strong genetic predisposition in family members of ILD cases, and supports the call for routine screening of individuals with a family history of ILD.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by an untied grant from a philanthropic family.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Sydney Local Health District Human Research Ethics Committee (X18-0193), University of Tasmania Health and Medical Human Research Ethics Committee (17775), and the Prince Charles Hospital Human Research Ethics Committee (53369) gave ethical approval for this study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors